In 2023, the cardiac glycosides market in Italy stood at 5.8 million US Dollars PPP. Forecasted sales from 2024 to 2028 show a year-on-year decline, with values falling from 5.6 million US Dollars PPP in 2024 to 4.8 million US Dollars PPP by 2028.
Year-on-year variations are as follows:
• 2025: -3.57%
• 2026: -5.56%
• 2027: -3.92%
• 2028: -2.04%
The compound annual growth rate (CAGR) for the period from 2024 to 2028 is approximately -3.77% per year.
Future trends to watch for include advancements in alternative cardiovascular therapies, increasing competition from generic drugs, and potential changes in healthcare policies and reimbursement models that could further impact market dynamics.
